ConductScience.org, home

Paper3691592

Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.

Nievel JG and 2 others. Eur J Clin Pharmacol, 1987. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension. Papers, record 3691592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3691592

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2019-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nievel JGJ G
2Havard CWC W
3Douglas-Jones APA P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
NicardipineMajor topic
PropranololMajor topic
Adult
Aged
Aged, 80 and over
Double-Blind Method
Drug Therapy, Combination
Drug Tolerance
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16527976Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.Postgrad Med J1984https://conductscience.org/library/papers/6527976PubMed
26131809Calcium antagonists. Pharmacodynamic effects and mechanism of action.Drugs1983https://conductscience.org/library/papers/6131809PubMed
33896278Nicardipine hydrochloride in essential hypertension--a controlled study.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3896278PubMed
43976506Coronary and systemic hemodynamic effects of nicardipine.Am J Cardiol1985https://conductscience.org/library/papers/3976506PubMed
56314104Calcium antagonists.Med J Aust1983https://conductscience.org/library/papers/6314104PubMed
64027144The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4027144PubMed
76310649Calcium antagonists: a new class of drugs.Pharmacol Ther1983https://conductscience.org/library/papers/6310649PubMed
84027146Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4027146PubMed
96417370Hemodynamic changes associated with long-term antihypertensive therapy with new calcium antagonist.Jpn Heart J1983https://conductscience.org/library/papers/6417370PubMed
106749700Antihypertensive effect of nicardipine hydrochloride in essential hypertension.Int J Clin Pharmacol Ther Toxicol1982https://conductscience.org/library/papers/6749700PubMed
113896280Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3896280PubMed
126336840Newer antihypertensive agents.Postgrad Med1983https://conductscience.org/library/papers/6336840PubMed
135824401Analysis of categorical data by linear models.Biometrics1969https://conductscience.org/library/papers/5824401PubMed
146209488Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease.J Cardiovasc Pharmacol1984https://conductscience.org/library/papers/6209488PubMed
156339198Calcium antagonists. Clinical use in the treatment of systemic hypertension.Drugs1983https://conductscience.org/library/papers/6339198PubMed
163896279Effect of nicardipine in elderly hypertensive patients.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3896279PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
8477149Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.Drugs Aging1993https://conductscience.org/library/papers/8477149PubMed
2666139Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2666139PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3691592

GET https://conductscience.org/api/papers/v1/3691592/authors